Camatche, Dexy Jill B.
HRN: 23-06-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM (VIAL)
05/18/2023
05/25/2023
IV
2g
Q6
PROM X 16 Hours; G1P0 39 3/7 Weeks AOG By LMP; Young Primigravid
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes